Glioblastoma multiforme (GBM) is a highly aggressive and malignant brain tumor that originates from glial cells, which provide support and protection to nerve cells in the brain. It is the most common and deadliest form of primary brain cancer in adults. GBM is characterized by its rapid growth, infiltrative nature, and ability to spread into nearby brain tissue.
Symptoms: The symptoms of GBM vary depending on the location of the tumor but commonly include headaches, seizures, cognitive impairment, personality changes, and motor deficits.
Treatment: Treatment options for GBM typically involve a combination of surgery, radiation therapy, and chemotherapy. However, due to the tumor's aggressive nature and ability to infiltrate surrounding brain tissue, complete removal is often challenging.
Prognosis: The prognosis for GBM is generally poor, with a median survival rate of around 15 months. Despite advancements in treatment, the tumor's high recurrence rate and resistance to therapy contribute to its low survival rates.
It is crucial for individuals diagnosed with GBM to consult with a team of healthcare professionals to determine the most appropriate treatment plan and support options.